The DCT is followed by the connecting tubule and then the cortical collecting tubule
The largest trial involving DSIP to date, which included a total of 107 volunteers, reported that the peptide was generally well-tolerated with mostly minor side effects, which included [8]: Low blood pressure Increased sweating Headache Nausea Vertigo Considering that the drop in blood pressure was reported as moderate to severe in some patients, researchers should consider hypotension as a potentially exclusionary criterion for DSIP research
Medium-to-high potency remedies include 200X, 30C, and 200C
Deficiency of Trem2 in macrophages worsens lipid accumulation and ferroptosis in TECs via IL-1-dependent CD36 upregulation, thus promoting DKD progression (201)
Understanding the potential side effects is crucial for both patients and healthcare providers
Any complications in the trial program or regulatory requirements could push this timeline further out